
Is Methotrexate ready for clinical use? A discussion with Professor Robin Christensen and Dr Anna Dossing
No se pudo agregar al carrito
Solo puedes tener X títulos en el carrito para realizar el pago.
Add to Cart failed.
Por favor prueba de nuevo más tarde
Error al Agregar a Lista de Deseos.
Por favor prueba de nuevo más tarde
Error al eliminar de la lista de deseos.
Por favor prueba de nuevo más tarde
Error al añadir a tu biblioteca
Por favor intenta de nuevo
Error al seguir el podcast
Intenta nuevamente
Error al dejar de seguir el podcast
Intenta nuevamente
-
Narrado por:
-
De:
Methotrexate is a well-established drug used in oncology, but could it also play a role in managing osteoarthritis? In this episode of Joint Action, Professor David Hunter is joined by Dr Anna Døssing and Professor Robin Christensen to explore the potential of methotrexate as a treatment for osteoarthritis pain.
They discuss:
- What methotrexate is and how it works
- Insights from a recent meta-analysis on its effectiveness and safety
- Why individual studies show mixed results
- Whether it might help people with hand or knee OA - especially those with signs of inflammation
- How dosing and side effects factor into clinical decision-making
Tune in for an honest, data-driven conversation about repurposing an old drug for a new purpose - and what it could mean for people living with osteoarthritis.
RESOURCES
- Editorial: Methotrexate for osteoarthritis—Ready for clinical use and in whom?: https://www.oarsijournal.com/article/S1063-4584(25)00973-2/abstract?
CONNECT WITH US
- Twitter: @ProfDavidHunter @jointactionorg
- Instagram: @osteoarthritisresearchgroup
- Email: osteoarthritis.research@sydney.edu.au
- Website: https://www.jointaction.info/podcast
Hosted on Acast. See acast.com/privacy for more information.
Todavía no hay opiniones